Abstract OBJECTIVES: The purpose of this study is to assess the clinicopathological characteristics of non-small-cell lung cancer (NSCLC) occurring in the left lingular division (LLD) in association with a proposal of the LLD-specific regional lymph node stations.
INTRODUCTION
Lung cancer continues to be a major cause of cancer mortality worldwide [1] . The presence of lymph node metastasis strongly affects the prognosis in non-small-cell lung cancer (NSCLC). In addition, adjuvant therapy may be indicated depending on the lymph node status, and incomplete or inaccurate nodal staging could potentially prevent some patients from receiving beneficial adjuvant therapy. Therefore, accurate lymph node assessment is extremely important. Many investigators have reported that NSCLC spreads to the hilar and mediastinal lymph nodes related to the primary tumour location, and lobe-specific lymph drainage has been advocated [2, 3] . This concept is important not only for systematic lymph node dissection, but also for selective lymph node dissection. There has been no consensus regarding the optimal dissection of mediastinal lymph nodes, especially for patients with early stage NSCLC. Whereas mediastinal lymph node dissection (MLND) may improve the prognosis, the frequency of postoperative morbidity as a result of recurrent laryngeal nerve injury, chylothorax and bronchopleural fistula can be increased. There are several reports that show that the morbidity associated with complete dissection was significantly higher than that seen with selective dissection [4, 5] . Therefore, it seems to be important to develop a reasonable and optimized approach for mediastinal and hilar lymph node dissection in NSCLC resection.
The left lung, unlike the right, contains no middle lobe, and the left superior division (LSD) and the left lingular division (LLD) are classified together as the left upper lobe. However, the LSD and LLD are discrete anatomical and functional units, and there is a possibility that lymph drainage from the LSD and LLD could be different. NSCLC occurring in the LLD is less common, and there are few reports regarding the prognosis and lymph drainage of LLD-NSCLC [6, 7] . In this retrospective study, we aimed to clarify the prognosis, and assess hilar and mediastinal lymph node involvement in patients with LLD-NSCLC who underwent surgery.
PATIENTS AND METHODS

Patient collection
Medical records of patients who underwent surgery for LLD-NSCLC from January 2000 to December 2009 in multiple institutions [Okayama University Hospital (n = 28), Osaka Medical Center for Cancer and Cardiovascular Diseases (n = 55), Osaka Prefectural Medical Center for Respiratory and Allergic Diseases (n = 35), Toneyama Hospital (n = 28), Dokkyo Medical University Hospital (n = 24) and Osaka University Hospital (n = 14)] were retrospectively reviewed. All patients underwent a curative operation for LLD-NSCLC. A curative operation was defined as the complete removal of the ipsilateral lobar, interlobar, hilar and mediastinal lymph nodes, together with a primary tumour. To archive accurate analysis of lymph node metastasis, we excluded the patients who underwent tumour resection less than lingulectomy or nonsystematic lymph node sampling. The status of mediastinal, hilar and interlobar lymph nodes was assessed according to the seventh edition of the tumour-node-metastasis (TNM) classification for lung cancer [8] . Disease stage was evaluated using chest radiography, enhanced chest and abdominal computed tomography (CT) scans, enhanced brain magnetic resonance imaging, radionuclide bone scan or 18-fluoro-2-deoxyglucose positron emission tomography CT scan and bronchoscopy.
Hilar node stations (N1) were classified as follows: hilar (#10), interlobar (#11), lobar (#12u), segmental (#13) and subsegmental (#14) node stations ( 
Determination of regional lymph node stations for left lingular division
We previously investigated which mediastinal lymph node stations should be examined during surgical intervention to diagnose p-N2 or lower stage disease in patients with NSCLC, and proposed three regional node stations for each lobe [9] . We then applied selective MLND in NSCLC patients, in whom no further MLND was performed when there was no metastasis shown in the regional mediastinal lymph node stations examined with a pathological technique during surgery [10] . In addition, we validated the effectiveness of intraoperative pathological examinations using a large-scale cohort [7] . As a result, we determined the regional node stations of LLD as #5, 7 and 11, although the number of LLD-NSCLC cases was small [7, 9] . Therefore, we also aimed to determine the regional node stations for LLD from the larger cohort in this study.
Statistical analysis
The overall survival (OS) and disease-free survival (DFS) were calculated from the date of surgery to the date of death or to the last follow-up for OS, and to the date of confirmed disease recurrence or death for DFS. Univariate analysis of OS and DFS was performed using the Kaplan-Meier method with log-rank testing. All data were analysed using the JMP software, version 9.0.0 (SAS Institute, Inc., Cary, NC, USA). For each analysis, probability values of <0.05 were considered significant.
RESULTS
Patient characteristics and prognosis of left lingular division non-small-cell lung cancer
The records of 184 patients who underwent complete tumour resection with systematic mediastinal and hilar node dissection for LLD-NSCLC were reviewed. Patient characteristics are summarized in Table 2 . The median age of patients was 68 years old (range, 
Lymph node involvement
To eliminate the effect of non-afferent lymph drainage via adjacent organ invasion, we examined the lymph node metastasis patterns in node-positive tumours ( p-N1/N2) without pathological invasion of adjacent structures ( p-T2/pl2 or lower stage disease). As a result, 10 node-positive tumours were eliminated and the remaining 42 node-positive tumours were examined (Fig. 2) . Among them, the most frequent metastatic site was station #12u, which occurred in 22 patients; there were 15 patients with station #5 (subaortic) metastasis and 13 patients with station #11 metastasis (Fig. 3A and B) . These three node stations were top three in frequency of metastasis and also single metastatic sites in some patients. Among 23 p-N2 patients, the frequent metastatic sites were superior mediastinal and aortic node stations, while metastasis to sub-carinal and inferior mediastinal and aortic node stations were rare (Fig. 3B ). Only 4 patients had metastases to #7 or #8. These 4 patients also had metastases to #11 or #12u ( patient no. 2, 7, 14 and 23 in Fig. 3B ). Five tumours showed skip metastases to mediastinal nodes without N1 node metastases, and all of these mediastinal nodes included the #5 subaortic node station ( patient no. 6, 13, 18, 19 and 20 in Fig. 3B ).
Regional node stations for left lingular division
Because the frequent metastatic lymph node stations were #12u lobar node, #5 subaortic node and #11 interlobar node in order, and because these three stations were also single metastatic sites in some patients, we assigned these lymph node stations as LLD-specific regional node stations for LLD-NSCLC (shown in grey in Fig. 4A ). We then investigated whether an intraoperative pathological examination of these selected regional node stations would accurately diagnose the metastasis status, and appropriately lead to a selective or complete MLND [7] . Here, the selective MLND includes the regional node stations (#5, #11, #12u) and #10, and the complete MLND includes all node stations shown in 4A (#4L to #7, and #10 to #12u). A total of 160 LLD-NSCLC patients with c-T2N1M0 or less extensive disease were studied for validation of regional node stations (Fig. 4B) . If the regional node stations for LLD-NSCLC had been examined in a pathological manner during surgery, 125 p-N0 and 5 p-N1 patients ( patient no. 1-5 in Fig. 5A ), diagnosed as having no metastasis, would have been subjected to selective MLND. The metastatic node stations of those 5 p-N1 patients were #10 in 1 patient, #13/14 in 3 patients and both of #10 and #13/14 in 1 patient, which are included in the selective MLND, thus leading to a curative surgery. As a result, patients diagnosed with no metastasis in these three selected regional lymph nodes would not have had lymph node metastasis in N2 nodes, and they would have received a selective MLND. On the other hand, the remaining 14 p-N1 and all 16 p-N2 patients, who were diagnosed with metastasis in the regional node stations, would have been subjected to a complete MLND (Fig. 5) . Finally, these regional lymph nodes could accurately predict the existence of p-N2 metastasis, and appropriately lead to a selective or complete MLND (Table 3) .
DISCUSSION
In this study, we retrospectively investigated the clinicopathological features of patients with surgically resected LLD-NSCLC. We found that the clinicopathological characteristics, including the lymph node metastasis pathway, of LLD-NSCLC are different from those of NSCLC in the right middle lobe (RML), which is located in the opposite middle lung field. It has been reported that lymph drainage from the RML extends to both superior and inferior mediastinal lymph nodes, including the sub-carinal nodes [6, 11] . Sakao et al. reported a similar frequency of metastasis to the superior mediastinal and sub-carinal nodes in RML-NSCLC (22 of 31 p-N2, 71.0% and 25 of 31 p-N2, 80.6%, respectively) [11] . In contrast, our results revealed a lower frequency of metastasis to the sub-carinal and inferior mediastinal nodes in LLD-NSCLC. Sub-carinal nodes were involved in 5 of 31 patients of p-N2/3 LLD-NSCLC (16.1%), and only 2 of 16 p-N2 patients (12.5%) with c-T2N1M0 or lower stage disease. These data correspond with the frequency of sub-carinal nodes metastasis previously reported in LSD-NSCLC (9.8-13.9%) [6, [12] [13] [14] .
We previously analysed the lymph node involvement patterns from each lobe or division including LSD-(in 32 p-N-positive patients) and LLD-NSCLC (in 4 p-N-positive patients) limited to c-T2N1M0 or less extensive disease [7] . In our previous study, we showed that the most frequent metastatic site from LSD-NSCLC was stations #5 (n = 13), #12u (n = 10) and #11 (n = 9). In addition, there were no sub-carinal or inferior mediastinal node metastases from LSD-NSCLC with c-T2N1M0 or less disease. On the other hand, LSD-NSCLC showed metastasis to #4 or #6 without #11 or #12u metastasis, and therefore we determined the regional lymph nodes of LSD-NSCLC as #4, #5 and #6. In regard to LLD-NSCLC, we had determined the regional lymph node stations as #5, #7 and #11 in the previous study. However, as we described in the previous report, the number of LLD-NSCLC was too small to obtain definitive conclusions. Therefore, in this study, we focused on the LLD-NSCLC and analysed the lymph node metastasis patterns from LLD-NSCLC thoroughly. As a result, we revised the regional lymph node stations as #5, #11 and #12u, using a larger series of LLD-NSCLC patients. If these revised regional node stations had been pathologically examined intraoperatively for the 160 LLD-NSCLC patients with c-T2N1M0 or lower stage disease, selective MLND would have been performed on 125 p-N0 and 5 p-N1 patients diagnosed with no metastasis, and complete MLND would have been carried out on 14 p-N1 and 16 p-N2 patients diagnosed with metastasis. Since those 5 p-N1 patients, initially diagnosed as having no metastasis, developed metastasis only to the lymph node stations within the area of a selective MLND, a selective MLND in association with a lingulectomy would have completely removed the local tumour. Thus, based on our revised node station examination, all patients would have been accurately assigned either a selective or complete MLND, resulting in no false negatives.
Limitations of this study include its retrospective nature and a relatively small sample number enrolled from each institution. With regard to prognosis, adjuvant chemotherapy regimens, which might influence the prognosis to some degree, differed between institutions.
In conclusion, an intraoperative pathological examination, using our proposed LLD-specific regional lymph node stations for LLD-NSCLC (#5, #11 and #12u), may accurately diagnose the status of node metastasis, and appropriately lead to a selective or complete MLND in patients with c-T2N1M0 or lower stage disease. 
